Clinical Trial Update: The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of Xuezhikang and atorvastatin on lipid levels in patients with dyslipidemia and prediabetes; recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Impaired Glucose Tolerance
• Prediabetes

Drugs mentioned

• Xuezhikang
• atorvastatin (atorvastatin)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Prediabetic State (IGT) | Phase 4 | Status: RECRUITING